It is demonstrated that increased matrix stiffness activates YAP/TEAD4-dependent transcriptional program and promotes ATP1A1 expression, thereby converting mechanical cues into chemical signaling output and finally promoting malignant phenotypes in the tumor.
Abstract
Extracellular matrix (ECM) stiffness is a critical biomechanical factor that plays a key role in tumor progression, influencing tumor behavior and driving its malignancy. Transcriptional co-activator yes-associated transcriptional regulator (YAP) is a well-established mechanosensitive regulator; however, the molecular mechanisms by which matrix stiffness-mediated YAP activation promotes tumor progression through transcriptional regulation remain incompletely defined. Here, using cross-omics analysis, in vitro, and in vivo experiments, we identified ATPase Na+/K+ transporting subunit alpha 1 (ATP1A1) as a novel target of YAP/TEA domain transcription factor 4 (TEAD4) mechano-responsive transcription factor complex, whose increased expression in stiff matrix promotes tumor cell proliferation. Mechanistically, we revealed that stiff matrix promotes YAP/TEAD4 binding to the ATP1A1 promoter, thereby upregulating its expression. Increased ATP1A1 in turn promotes intracellular calcium signaling and activates the nuclear factor-kappa B (NF-κB) pathway, thereby promoting C-X-C motif chemokine ligand 1 (CXCL1) expression and secretion, and subsequently enhances tumorigenic potential. These findings demonstrate that increased matrix stiffness activates YAP/TEAD4-dependent transcriptional program and promotes ATP1A1 expression, thereby converting mechanical cues into chemical signaling output and finally promoting malignant phenotypes in the tumor. Furthermore, these findings suggest that CXCL1 may contribute to stiffness-associated tumor progression and warrant further investigation as a potential therapeutic target.
Abstract The mechanosensitive ion channel Piezo1 translates physical cues from the tumor microenvironment—including extracellular matrix stiffness, fluid shear stress, and compressive forces—into intracellular calcium signals and downstream cascades, playing a pivotal role in cancer. Piezo1 exhibits pronounced tumor-ty...
Hai-Yan Jiang, Ying Liu, Fei Xue et al.· Drug Design, Development and...· 0 citations
This review summarizes recent advances in how NF2 regulates YAP/TAZ and AMOT functions, focusing on their roles in tumor formation, metastasis, and angiogenesis.
Yu Wang, Fa-Xing Yu· Cold Spring Harbor Perspecti...· 0 citations
It is shown that the transcriptional cofactor LBH drives mutation-independent Wnt activation and malignant progression in GC via a tumour microenvironment-regulated post-translational stabilization mechanism, elucidate a critical tumour–stroma crosstalk mechanism and establish the targeted disruption of the LBH–β-caten...
Zhi-Xiong Su, Guifeng Zhang, J. Zhong et al.· Cell Death & Disease· 0 citations
This review summarizes the Piezo1-mediated mechanotransduction networks involved in the fibrosis-to-cancer transition and discusses emerging “mechano-immunotherapeutics,” including targeted Piezo1 modulators, precision nanodelivery systems, and ECM-normalizing agents (e.g., LOX inhibitors and losartan).
Linfeng Guo, Jia Wang, Bao-Yi Ni et al.· Frontiers in Pharmacology· 1 citation· ⚡1
PURPOSE
Increased extracellular matrix stiffness is a critical driver of epithelial-mesenchymal transition (EMT) and metastatic progression in breast cancer; however, effective pharmacological strategies targeting intracellular mechanotransduction remain limited. This study investigated whether oxymatrine, a bioactive...
Findings identify a novel PRDX1-PRMT5 axis that activates Wnt/β-catenin signaling, highlighting a potential therapeutic strategy for CRC by targeting this pathway to suppress tumor progression and remodel the immune microenvironment.
Nianhua Yu, Xi Li, Jin-Li Han et al.· International Journal of Bio...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.